propranolol has been researched along with Angioma, Cavernous in 15 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Angioma, Cavernous: A tumor-like mass with large vascular space that is filled with blood or lymph.
Excerpt | Relevance | Reference |
---|---|---|
"In this case, we describe an evident hemorrhagic brainstem cavernous malformation successfully treated with a planned sequence of surgical evacuation of the hematoma followed by postoperative propranolol therapy." | 7.96 | Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol. ( Armstrong, J; Greenan, K; Hoffman, JE; Ryan, M; Wilkinson, C; Wittenberg, B, 2020) |
"Kaposiform hemangioendothelioma is a rare vascular tumor in children." | 5.37 | Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. ( de Blaauw, I; Hermans, DJ; Kool, LJ; van Beynum, IM; van der Vijver, RJ; van der Vleuten, CJ, 2011) |
"In this case, we describe an evident hemorrhagic brainstem cavernous malformation successfully treated with a planned sequence of surgical evacuation of the hematoma followed by postoperative propranolol therapy." | 3.96 | Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol. ( Armstrong, J; Greenan, K; Hoffman, JE; Ryan, M; Wilkinson, C; Wittenberg, B, 2020) |
" The adverse events (AEs) were observed." | 1.46 | Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas. ( Lu, Y; Wang, Y; Yang, Y; Zhang, J; Zhang, X, 2017) |
"Kaposiform hemangioendothelioma is a rare vascular tumor in children." | 1.37 | Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment. ( de Blaauw, I; Hermans, DJ; Kool, LJ; van Beynum, IM; van der Vijver, RJ; van der Vleuten, CJ, 2011) |
" A dosage of 2 mg/kg/d, is usually employed with a dosing interval of 8 hours." | 1.37 | [Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations]. ( López-Gutiérrez, JC; Ruiz-Rodriguez, R; Sánchez-Carpintero, I, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.67) | 29.6817 |
2010's | 12 (80.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Zhanatkyzy, A | 1 |
Gorbunov, D | 1 |
Ivanova-Razumova, T | 1 |
Baigalkanova, A | 1 |
Manabay, A | 1 |
Hoffman, JE | 1 |
Ryan, M | 1 |
Wittenberg, B | 1 |
Armstrong, J | 1 |
Greenan, K | 1 |
Wilkinson, C | 1 |
Paul, SP | 1 |
Boyd, GM | 1 |
Kaliaperumal, C | 1 |
Brichacek, M | 1 |
Naeem, A | 1 |
Filler, G | 1 |
Hammond, R | 1 |
Yazdani, A | 1 |
Ranger, A | 1 |
Ramdhani, D | 1 |
Seedat, RY | 1 |
Akcam, M | 1 |
Pirgon, O | 1 |
Salman, H | 1 |
Kockar, C | 1 |
Wang, Y | 1 |
Zhang, X | 1 |
Yang, Y | 2 |
Zhang, J | 1 |
Lu, Y | 1 |
Kumar, V | 1 |
Murali, M | 1 |
Pastore, S | 1 |
Londero, M | 1 |
Cont, G | 1 |
Di Leo, G | 1 |
Ventura, A | 1 |
Hermans, DJ | 1 |
van Beynum, IM | 1 |
van der Vijver, RJ | 1 |
Kool, LJ | 1 |
de Blaauw, I | 1 |
van der Vleuten, CJ | 1 |
Schöni, MH | 1 |
Kernland Lang, K | 1 |
Sánchez-Carpintero, I | 1 |
Ruiz-Rodriguez, R | 1 |
López-Gutiérrez, JC | 1 |
Hon, KL | 1 |
Burd, A | 1 |
Chu, WC | 1 |
Lee, V | 1 |
Li, CK | 1 |
Condat, B | 1 |
15 other studies available for propranolol and Angioma, Cavernous
Article | Year |
---|---|
Giant cardiac cavernous haemangioma of the right atrium in a newborn successfully managed using combined therapy.
Topics: Heart Atria; Heart Neoplasms; Hemangioma, Cavernous; Humans; Infant, Newborn; Neoplasm Recurrence, L | 2023 |
Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol.
Topics: Child, Preschool; Hemangioma, Cavernous; Hemangioma, Cavernous, Central Nervous System; Hematoma; Hu | 2020 |
Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas: Correspondence.
Topics: Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Cavernous; Humans; Infant; Propranolol; Skin Ne | 2017 |
Letter to the Editor. Propranolol for pediatric intracerebral cavernomas: unanswered questions.
Topics: Brain Neoplasms; Child; Hemangioma, Cavernous; Humans; Propranolol | 2018 |
Congenital Calvarial Hemangioma.
Topics: Child, Preschool; Hemangioma, Cavernous; Humans; Male; Parietal Bone; Propranolol; Skull Neoplasms; | 2018 |
Recurrent parotid cavernous haemangioma in an adolescent, successfully treated with Propranolol.
Topics: Adolescent; Hemangioma, Cavernous; Humans; Male; Parotid Neoplasms; Propranolol; Recurrence; Vasodil | 2018 |
Multiple gastrointestinal hemangiomatosis successfully treated with propranolol.
Topics: Adolescent; Anemia; Colonic Neoplasms; Endoscopy, Gastrointestinal; Fatigue; Hemangioma, Cavernous; | 2015 |
Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas.
Topics: Administration, Cutaneous; Female; Hemangioma, Cavernous; Humans; Infant; Infant, Newborn; Male; Pro | 2017 |
Large cavernous hemangioma.
Topics: Abdomen; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Hemangioma, Cavernous; Human | 2010 |
Refractory iron-deficiency anaemia in a child with portal cavernoma.
Topics: Anemia, Iron-Deficiency; Antihypertensive Agents; Child; Hemangioma, Cavernous; Humans; Hypertension | 2011 |
Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents, Phytogenic; Disseminated Intravascular Coagulati | 2011 |
[Hemangiomas in childhood].
Topics: Adrenergic beta-Antagonists; Disease Progression; Female; Hemangioma; Hemangioma, Cavernous; Humans; | 2011 |
[Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Bradycardia; Bronchial Spasm; Clinical Trials | 2011 |
Propranolol for infantile hemangiomas: strawberry matters?
Topics: Adrenergic beta-Antagonists; Female; Hemangioma, Cavernous; Humans; Infant; Male; Propranolol | 2012 |
[Jaundice and portal cavernoma].
Topics: Antineoplastic Agents; Cholestasis, Extrahepatic; Cohort Studies; Diagnosis, Differential; Follow-Up | 2006 |